IVF Services Market Outlook 2026
The global In vitro fertilization services market size generated $12,506 million in 2018, and is projected to reach $25,563 million by 2026, growing at a CAGR of 9.3% from 2019 to 2026.
In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm in vitro. The process involves stimulating a woman's ovulatory, removing an ovum from the woman's ovaries, and letting sperm fertilize them in a liquid in a laboratory. IVF is one of the widely used treatments to assist couples with infertility issues, which is a key factor that drives the growth of the IVF services Market globally.
The global In vitro fertilization services market is anticipated to exhibit significant growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income worldwide. However, high cost & complications associated with IVF treatment and low awareness for IVF in underdeveloped regions hinder the growth of the IVF services market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and low cost of IVF services in developing countries as compared to developed countries are expected to offer remunerative opportunities for market expansion.
By Cycle Type
The cycle type segment is classified into fresh (non-donor) IVF cycles, thawed (non-donor) IVF cycles, and donor egg IVF cycles. The fresh IVF cycles (non-donor) was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period, owing to higher success rate, as fresh embryo transfers lead to better pregnancy and birth rates compared to those who received frozen embryos.
By Cycle Type
Fresh Cycle holds the dominant position in 2018 and would continue to maintain the lead over the forecast period.
By End User
Depending on end user, the In vitro fertilization services market is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. The clinical research institutes segment is projected to exhibit the highest growth during the forecast period. This is attributed to the fact that majority of the research on fertility problems and their possible treatments, including IVF are carried out in clinical research institutes. In addition, technological advancement in IVF devices and services is the major driving factor for the growth of the IVF clinical research institutes segment. However, fertility clinics and specialty hospitals play a crucial role in providing IVF treatments to couples seeking assistance for infertility treatments. In addition, availability of a wide range of fertility treatments under one roof coupled with government reimbursements majorly drive the growth of fertility clinic segment.
By End User
Clinical Research Institutes segment is projected as one of the most lucrative segments.
Region wise, the IVF services market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest market share in 2018, and is expected to retain its dominance throughout the forecast period. This is attributed to presence of high population base in countries such as India & China, increase in awareness about IVF treatment, low costs of IVF treatments, rise in number of infertile population, and surge in disposable income.
Asia-Pacific region would exhibit the highest CAGR of 12.0% during 2019-2026.
The key players profiled in the global IVF industry include Ambroise Paré Group, amedes MVZ Cologne GmbH, AMP Center St Roch, AVA Clinic Scanfert, Bangkok IVF Center, Bangkok IVF center (Bangkok Hospital), Betamedics, Biofertility Center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bourn Hall International, Cardone Reproductive Medicine and Infertility, LLC, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chelsea and Westminster Hospital (Assisted Conception Unit), Cloudnine Fertility, Conceptions Reproductive Associates of Colorado, Cyprus IVF Centre, Dansk Fertilitetsklinik, EUVITRO S.L.U., Fakih IVF Fertility Center, Fertility and Gynecology Center Monterey Bay IVF, Fertility Associates, Fertility Center Berlin, Fertility Center of San Antoni, Fertility First, FIV Marbella, Fivet Centers Prof. Zech, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, Heidelberg University Hospital, Houston Fertility Center, International Centre for Reproductive Medicine, ICRM, IVF Canada, IVF NAMBA Clinic, IVF Panama Center for Reproduction Punta Pacífica, IVF Spain, IVI Panama, Ivinsemer, KL Fertility & Gynaecology Centre, Lifesure Fertility and Gynaecology Centre, LIV Fertility Center, Manipal Fertility, Maria Fertility Hospital, MD Medical Group, Medfem Fertility Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., New hope fertility center, Oak Medical Group/Oak Clinic, OVA IVF Clinic Zurich, Procrea Fertility, RAPRUI Srl, Repromed, SAFE Fertility Center, Sanno Hospital, Servy Massey Fertility Institute, Shanghai Ji Ai Genetics & IVF Institute, Shanghai United Family Hospital, Sher Institute for Reproductive Medicine (SIRM), Southend Fertility and IVF, StorkKlinik (Stork IVF Clinic), The ARC-STER Center, The Bridge Centre, The Cape Fertility Clinic, The Hugh Wynter Fertility Management Unit, The Lister Fertility Clinic, The Montreal Fertility Center, Thomson Medical Pte. Ltd., Trianglen Fertility Clinic, TRIO Fertility, Virtus Health, Vitanova, VivaNeo - Medical Center Kinderwens, and Wunschkinder.
Key Benefits for IVF Services Market:
- The study provides an in-depth IVF services market analysis with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing IVF services market size.
- Comprehensive analysis of all regions is provided to determine the In vitro fertilization services market forecast.
- Key players are profiled to understand the competitive outlook of the global IVF services market share.
IVF Services Market Report Highlights
By Cycle Type
By End User
The adoption of IVF procedure is expected to increase in the near future due to rise in infertile population across the world and upsurge in fertility tourism in the developing countries. In addition, increase in success rate of IVF, surge in disposable income, and rise in trend of delayed pregnancies are expected to drive the market growth in the coming future. However, complications associated with the use of IVF and increase in procedure cost are expected to hinder the market growth.
Asia-Pacific is expected to dominate the IVF services market during the forecast period, followed by Europe. Emerging fertility tourism destinations such as India, Thailand, Japan, and Australia are chiefly responsible for the market growth in Asia-Pacific, due to the availability of skilled workforce and rise in healthcare awareness across these nations. In addition, rise in funding in R&D by government and private companies, introduction of fertility programs, and implementation of favorable regulatory policies for the development of IVF products are projected to supplement the growth of the European IVF services market. Efforts of Human Fertilisation and Embryology Authority (HFEA) and the acceptance of three parent IVF methods in countries, such as the UK, are further anticipated to support the growth of the Europe IVF services market.
Japan, China, U.S., India, and France are the prominent countries for IVF procedures. This is attributed to the affordability and reimbursements available for IVF cycles. Countries across Western Europe exhibit an alleviated response toward IVF procedures owing to favorable regulations and lesser ethical obligations. However, ethical issues and lack of regulatory policies hamper the growth of the IVF services market in Latin America and some parts of Middle East.